Shoshana Shendelman - Dec 14, 2021 Form 4/A - Amendment Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Stock symbol
APLT
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/11/2022, 05:42 PM
Date Of Original Report
Dec 16, 2021
Previous filing
Sep 14, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +121K +33.19% $0.00 485K Dec 14, 2021 Direct F1
holding APLT Common Stock 1.75M Dec 14, 2021 See footnote F2
holding APLT Common Stock 1.49M Dec 14, 2021 See footnote F3
holding APLT Common Stock 710K Dec 14, 2021 See footnote F4
holding APLT Common Stock 290K Dec 14, 2021 See footnote F5
holding APLT Common Stock 88.4K Dec 14, 2021 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 14, 2022, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
F2 Through a grantor retained annuity trust.
F3 Through a family trust controlled by the reporting person's spouse.
F4 Through the reporting person's spouse.
F5 Through a family trust controlled by the reporting person.
F6 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.

Remarks:

This amendment is being filed solely to correct the vesting schedule for the compensatory Restricted Stock Units reported on the Reporting Person's Form 4 filed on December 16, 2021.